Symptoms & Multisystem Involvement in EDS
Last updated:
Ehlers-Danlos Syndrome (EDS) is a multisystem connective tissue disorder that goes beyond flexible joints. Because connective tissue is everywhere, EDS causes widespread symptoms including joint instability, digestive problems, and nervous system dysfunction like POTS and MCAS.
Key Takeaways
- • EDS is a multisystemic disorder that affects connective tissue throughout the entire body.
- • Joint instability in EDS frequently causes subluxations, dislocations, and chronic pain.
- • Many EDS patients also experience nervous and immune system issues like POTS and MCAS.
- • Digestive dysmotility is common in EDS, leading to severe bloating, acid reflux, and irregular bowel habits.
- • Because symptoms are so diverse, EDS is often misdiagnosed as fibromyalgia, anxiety, or irritable bowel syndrome.
Ehlers-Danlos Syndrome (EDS) is far more than a condition of “stretchy skin and flexible joints.” Because connective tissue—the “glue” of the body—is found in nearly every organ system, EDS is a multisystemic disorder [1][2]. This means symptoms that may seem unrelated, such as a racing heart, joint pain, and digestive issues, are often actually connected by the same underlying tissue fragility [3][4].
How EDS Affects the Body
The Joints: Beyond Flexibility
While flexibility is a hallmark of EDS, it often comes at the cost of stability. Patients frequently experience subluxations (partial dislocations) and full dislocations, where the joint slips out of its socket [5][6]. This constant instability leads to chronic musculoskeletal pain and early-onset osteoarthritis [5].
The Autonomic Nervous System & Immune System: POTS and MCAS
Many people with EDS experience a “triad” of systemic issues involving the nervous and immune systems:
- Postural Orthostatic Tachycardia Syndrome (POTS): A form of dysautonomia where the body struggles to keep blood flowing to the brain when you stand up. Symptoms include a rapid increase in heart rate upon standing, dizziness or fainting, and extreme fatigue or “brain fog” [3][7].
- Mast Cell Activation Syndrome (MCAS): A condition where the immune system’s mast cells mistakenly release inflammatory chemicals. This can cause unexplained allergic-like reactions, hives, flushing, and severe gastrointestinal distress [6].
The Digestive System: GI Dysfunction
Connective tissue lines the entire gastrointestinal (GI) tract. When this tissue is too stretchy, it can lead to dysmotility, where the digestive system moves too slowly or inconsistently [8][2]. Common GI symptoms in EDS include [9][10]:
- Severe bloating and abdominal pain
- Chronic constipation or diarrhea
- Gastroesophageal Reflux Disease (GERD/Heartburn)
The Long Road to Diagnosis: Common Mislabels
Because EDS symptoms are so diverse, patients often spend years being “mislabeled” before finding the right answer [11]. It is very common for EDS patients to have been previously diagnosed with [12][13][6]:
- Fibromyalgia: Due to widespread chronic pain [14].
- Anxiety or Panic Disorder: Because the rapid heart rate of POTS can feel like a panic attack [12][15].
- Chronic Fatigue Syndrome (ME/CFS): Due to the profound, systemic exhaustion common in EDS [4].
- Irritable Bowel Syndrome (IBS): Before the broader GI dysmotility is understood [3].
The Psychological and Emotional Toll
Living for years with debilitating symptoms that no one can explain takes a significant psychological toll [16][17]. Many patients report experiencing medical gaslighting, where their physical symptoms were dismissed as “all in their head” or “just stress” [18][19].
This history of invalidation can lead to high rates of secondary anxiety, depression, and a loss of trust in the medical system [15][20]. Receiving a diagnosis is often a powerful emotional turning point, providing the validation that your symptoms are real, biological, and not your fault [21][22]. Management is most successful when it includes a multidisciplinary approach that addresses both physical symptoms and psychological well-being [6][23].
Frequently Asked Questions
Why does Ehlers-Danlos Syndrome affect so many different parts of the body?
Are a racing heart and dizziness common symptoms of EDS?
Why do I have stomach issues and bloating with EDS?
Is it common for EDS to be misdiagnosed at first?
How are allergic reactions or hives related to Ehlers-Danlos Syndrome?
Questions for Your Doctor
- • Could my symptoms like racing heart, dizziness, and stomach issues be related to my connective tissue rather than being separate problems?
- • How do we distinguish between my EDS-related pain and other conditions like fibromyalgia?
- • Since EDS can affect my autonomic nervous system, should I be screened for POTS (Postural Orthostatic Tachycardia Syndrome)?
- • What is the best way to manage my frequent joint subluxations without causing more tissue damage?
- • Are my gastrointestinal symptoms, like bloating and reflux, common in people with my type of EDS?
Questions for You
- • Which of my 'seemingly unrelated' symptoms (e.g., joint pain, dizziness, stomach issues) tend to flare up at the same time?
- • How many different specialists have I seen for these symptoms, and have they ever communicated with each other?
- • Have I ever been told my physical symptoms were 'just anxiety' or 'stress,' even when I felt something was physically wrong?
- • How does the unpredictability of my symptoms affect my mental health and daily planning?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
A review of Ehlers-Danlos syndrome.
Miller E, Grosel JM
JAAPA : official journal of the American Academy of Physician Assistants 2020; (33(4)):23-28 doi:10.1097/01.JAA.0000657160.48246.91.
PMID: 32175940 - 2
An overview of Ehlers Danlos syndrome and the link between postural orthostatic tachycardia syndrome and gastrointestinal symptoms with a focus on gastroparesis.
Wu W, Ho V
Frontiers in neurology 2024; (15()):1379646 doi:10.3389/fneur.2024.1379646.
PMID: 39268060 - 3
Prevalence of joint hypermobility syndromes in pediatric postural orthostatic tachycardia syndrome.
Boris JR, Bernadzikowski T
Autonomic neuroscience : basic & clinical 2021; (231()):102770 doi:10.1016/j.autneu.2020.102770.
PMID: 33388686 - 4
The Mystery of Ehlers-Danlos Syndrome: An Autobiographical Case Report.
Tapasak BE, Malis DJ
Cureus 2022; (14(1)):e21601 doi:10.7759/cureus.21601.
PMID: 35228959 - 5
Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder.
Gazit Y, Jacob G, Grahame R
Rambam Maimonides medical journal 2016; (7(4)) doi:10.5041/RMMJ.10261.
PMID: 27824552 - 6
Recognizing and Effectively Managing Hypermobility-Related Conditions.
Russek LN, Stott P, Simmonds J
Physical therapy 2019; (99(9)):1189-1200 doi:10.1093/ptj/pzz078.
PMID: 31158283 - 7
Dysautonomia in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders is associated with exercise intolerance and cardiac atrophy.
Ruiz Maya T, Fettig V, Mehta L, et al.
American journal of medical genetics. Part A 2021; (185(12)):3754-3761 doi:10.1002/ajmg.a.62446.
PMID: 34331416 - 8
Mechanisms and management of gastrointestinal symptoms in postural orthostatic tachycardia syndrome.
Tu Y, Abell TL, Raj SR, Mar PL
Neurogastroenterology and motility 2020; (32(12)):e14031 doi:10.1111/nmo.14031.
PMID: 33140561 - 9
Prevalence and Predictors of Gastrointestinal Dysmotility in Patients with Hypermobile Ehlers-Danlos Syndrome: A Tertiary Care Center Experience.
Alomari M, Hitawala A, Chadalavada P, et al.
Cureus 2020; (12(4)):e7881 doi:10.7759/cureus.7881.
PMID: 32489735 - 10
Rectal hyposensitivity: a common pathophysiological finding in patients with constipation and associated hypermobile Ehlers-Danlos syndrome.
Choudhary A, Vollebregt PF, Aziz Q, et al.
Alimentary pharmacology & therapeutics 2022; (56(5)):802-813 doi:10.1111/apt.17104.
PMID: 35758859 - 11
Health care supply in patients with Ehlers-Danlos syndromes and generalized hypermobility spectrum disorder: a German perspective.
Rauterberg J, Hock M, Kernich N, et al.
Orphanet journal of rare diseases 2025; (20(1)):436 doi:10.1186/s13023-025-03937-4.
PMID: 40819036 - 12
Comorbidity, misdiagnoses, and the diagnostic odyssey in patients with hypermobile Ehlers-Danlos syndrome.
Halverson CME, Cao S, Perkins SM, Francomano CA
Genetics in medicine open 2023; (1(1)):100812 doi:10.1016/j.gimo.2023.100812.
PMID: 39669244 - 13
Chronic Low Back Pain Occurring in Association With Hypermobility Spectrum Disorder and Ehlers-Danlos Syndrome.
Eseonu KC, Payne K, Ward S, et al.
International journal of spine surgery 2021; (15(3)):449-457 doi:10.14444/8067.
PMID: 33963027 - 14
Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.
Di Stefano G, Celletti C, Baron R, et al.
European journal of pain (London, England) 2016; (20(8)):1319-25 doi:10.1002/ejp.856.
PMID: 26919608 - 15
Prevalence of psychiatric and sleep disorders and their impact on quality of life in children with hypermobile Ehlers-Danlos syndrome: an observational study.
Hertel AK, Jones JT, Lytch A, et al.
Rheumatology international 2025; (45(4)):81 doi:10.1007/s00296-025-05836-0.
PMID: 40131551 - 16
Predictors of pain and mobility disability in the hypermobile Ehlers-Danlos syndrome.
Kalisch L, Hamonet C, Bourdon C, et al.
Disability and rehabilitation 2020; (42(25)):3679-3686 doi:10.1080/09638288.2019.1608595.
PMID: 31060411 - 17
The Underrecognized Conditions of Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders in Women.
Robbins K
Nursing for women's health 2022; (26(3)):174-183 doi:10.1016/j.nwh.2022.03.005.
PMID: 35533735 - 18
Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
Estrella E, Frazier PA
Disability and rehabilitation 2024; (46(4)):731-740 doi:10.1080/09638288.2023.2176554.
PMID: 36772820 - 19
Health-Related Quality of Life in Midlife and Older Women With Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
Anderson LK
Nursing for women's health 2026; doi:10.1016/j.nwh.2025.09.006.
PMID: 41587761 - 20
Symptom complaints and impact on functioning in youth with hypermobile Ehlers-Danlos syndrome.
Tran ST, Jagpal A, Koven ML, et al.
Journal of child health care : for professionals working with children in the hospital and community 2020; (24(3)):444-457 doi:10.1177/1367493519867174.
PMID: 31370685 - 21
Recurrent Depression and Borderline Personality Disorder in a Patient with Ehlers-Danlos Syndrome.
Espiridion ED, Daniel A, Van Allen JR
Cureus 2018; (10(12)):e3760 doi:10.7759/cureus.3760.
PMID: 30820380 - 22
Defining the Chronic Complexities of hEDS and HSD: A Global Survey of Diagnostic Challenges, Life-Long Comorbidities, and Unmet Needs.
Daylor V, Griggs M, Weintraub A, et al.
Journal of clinical medicine 2025; (14(16)) doi:10.3390/jcm14165636.
PMID: 40869462 - 23
Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
Bennett SE, Walsh N, Moss T, Palmer S
Disability and rehabilitation 2022; (44(18)):5231-5240 doi:10.1080/09638288.2021.1933618.
PMID: 34101520
This page explains the multisystem symptoms of Ehlers-Danlos Syndrome for educational purposes. It is not a substitute for professional medical advice or diagnosis from a qualified healthcare provider.
Stay up to date
Get notified when new research about Ehlers Danlos Syndrome (EDS) is published.
No spam. Unsubscribe anytime.